### In vitro / physico-chemical Data <a id="invitro-and-physico-chemical-data"></a>

A literature search was performed to collect available information on physicochemical properties of Warfarin. The obtained information from literature is summarized in the table below. 

| **Parameter**   | **Unit** | **Value** | Source                                     | **Description**                                 |
| :-------------- | -------- | --------- | ------------------------------------------ | ----------------------------------------------- |
| MW              | g/mol    |308.33     |                | Molecular weight                                |
| pK<sub>a</sub>  |  -        | 5.03 (Acid)          |          | Acid dissociation constant                      |
| Solubility (pH) |  17 at pH7        |     mg/mL      |                | Aqueous Solubility, FaSSIF, ...                 |
| fu              | %        |           |                | Fraction unbound in plasma                      |

### Clinical Data  <a id="clinical-data"></a>

A literature search was performed to collect available clinical data on Warfarin in healthy adults.

#### Model Building S-Warafin <a id="model-building"></a>

The following studies were used for model building (training data):

| **Dose [mg]** | **Dosing** | **PK data** |**Dataset**| **Reference** |
| --------------- | ------------------- | ----------------------- | ----------------- |----------------- |
| 15| po, sd |plasma|training|[Soon 2006](#5-references)| 
| 25| po, sd |plasma|training|[Schwartz 2008](#5-references)| 

iv = intravenous; po = oral administration; tab = tablet administration; sd = single dose; qd = once daily

#### Model Verification S- Warfarin <a id="model-verification"></a>

The following studies were used for model verification:

| **Dose [mg]** | **Dosing** | **PK data** |**Dataset**| **Reference** |
| --------------- | ------------------- | ----------------------- | ----------------- |----------------- |
| 0.375| iv, tab, fasted, sd |plasma|verification|[O'Sullivan 1993](#5-references)| 
| 7.5| po, tab, fed, sd |plasma|verification|[Frymoyer 2010](#5-references)| 
| 10| po, tab, fasted, sd |plasma|verification|[Kim 2001](#5-references)| 
| 10| po, tab, fasted, sd |plasma|verification|[Lilja 2007](#5-references)| 
| 10| po, tab, fasted, sd |plasma|verification|[Ngo 2010](#5-references)| 
| 10| po, tab, fasted, sd |plasma|verification|[Turpeinen 2013](#5-references)| 
| 13| po, tab, fed, sd |plasma|verification|[Weber 1999](#5-references)| 
| 15| po, tab, fasted, sd |plasma|verification|[Schwartz 2009](#5-references)| 
| 20| po, tab, fasted, sd |plasma|verification|[Ouellet 2006](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Almeida 2008](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Dingemande 2013](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[He 2007](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Macha 2013](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Malhotra 2011](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Rahimy 2002](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Sanwald Ducray 2014](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Stockis 2013](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Toon 2087](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Toon 1990](#5-references)| 
| 25| po, tab, fed, sd |plasma|verification|[Mallikaarjun 1999](#5-references)| 
| 25| po, tab, fed, sd |plasma|verification|[Sidharta 2014](#5-references)| 
| 25| po, tab, fed, sd |plasma|verification|[Soon 2006](#5-references)| 
| 25| po, tab, fed, sd |plasma|verification|[Yin 2011](#5-references)| 
| 30| po, tab, fed, sd |plasma|verification|[Liao 1996](#5-references)| 


iv = intravenous; po = oral administration; tab = tablet administration; sd = single dose; qd = once daily


#### Model Verification R- Warfarin <a id="model-verification"></a>

The following studies were used for model verification:

| **Dose [mg]** | **Dosing** | **PK data** |**Dataset**| **Reference** |
| --------------- | ------------------- | ----------------------- | ----------------- |----------------- |
| 25| po, tab, fasted, sd |plasma|verification|[Almeida 2008](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Dingemande 2013](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[He 2007](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Malhotra 2011](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Rahimy 2002](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Stockis 2013](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Toon 2087](#5-references)| 
| 25| po, tab, fasted, sd |plasma|verification|[Toon 1990](#5-references)| 
| 25| po, tab, fed, sd |plasma|verification|[Mallikaarjun 1999](#5-references)| 
| 25| po, tab, fed, sd |plasma|verification|[Sidharta 2014](#5-references)| 
| 25| po, tab, fed, sd |plasma|verification|[Soon 2006](#5-references)| 
| 25| po, tab, fed, sd |plasma|verification|[Yin 2011](#5-references)| 

iv = intravenous; po = oral administration; tab = tablet administration; sd = single dose; qd = once daily
